NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy

• Autores principales: Simone Dal Bello (Autor), Simone Lorenzut (Autor), Emma Saccomano (Autor), Yan Tereshko (Autor), Gian Luigi Gigli (Autor), Carlo Ennio Pucillo (Autor), Mariarosaria Valente (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2024-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Recently, research on the pathogenesis of multiple sclerosis (MS) has focused on the role of B lymphocytes and the possibility of using specific drugs, such as Ocrelizumab and Rituximab, directed toward these cells to reduce inflammation and to slow disease progression. Objective: We aim...